PWMG
CRL icon

Provence Wealth Management Group’s Charles River Laboratories CRL Stock Holding History

Provence Wealth Management Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$69K Hold
292
– – 0.04% 200
2023
Q3 		$57.2K Buy
+292
New +$59.9K 0.04% 197

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Provence Wealth Management Group's CRL Position: Q4 2023 in Review

Provence Wealth Management Group held its Charles River Laboratories (CRL) position steady in Q4 2023 at 292 shares worth $69K. The position accounts for 0.04% of the portfolio, ranked #200.

Provence Wealth Management Group first reported a position in CRL in Q3 2023 and has held it in 2 quarters since. 634 funds tracked by Wall St. Rank hold CRL as of Q4 2023.

  • Provence Wealth Management Group held 292 shares of Charles River Laboratories worth $69K as of Q4 2023.
  • Provence Wealth Management Group left its Charles River Laboratories share count unchanged in Q4 2023.
  • Charles River Laboratories made up 0.04% of Provence Wealth Management Group's portfolio in Q4 2023, its #200 holding.
  • Provence Wealth Management Group first reported a position in Charles River Laboratories in Q3 2023 and has held it in 2 quarters since.
  • 634 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2023.

Based on Provence Wealth Management Group's 13F filing for Q4 2023, filed 6 Feb 2024.